Literature DB >> 11444847

New insights into the regulation of cathepsin K gene expression by osteoprotegerin ligand.

S Corisdeo1, M Gyda, M Zaidi, B S Moonga, B R Troen.   

Abstract

Cathepsin K plays a key role in bone resorption. We provide the first evidence that osteoprotegerin ligand (OPGL), a critical pro-resorptive cytokine, acutely stimulates the expression of cathepsin K in osteoclasts. We used in situ RT-PCR and real time quantitative RT-PCR to analyze cathepsin K gene expression. OPGL enhanced cathepsin K mRNA levels in mature osteoclasts isolated from rat neonatal long bones. OPGL together with macrophage colony-stimulating factor (M-CSF) also stimulated cathepsin K gene expression in monocytic cells and multinucleate osteoclasts in bone marrow cultures. Real time quantitative RT-PCR demonstrated high levels of cathepsin K mRNA in bone marrow cultures, paralleling the degree of osteoclastogenesis. We therefore suggest that OPGL enhances bone resorption, at least in part, by inducing cathepsin K gene expression. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11444847     DOI: 10.1006/bbrc.2001.5127

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

Review 1.  RNA therapeutics targeting osteoclast-mediated excessive bone resorption.

Authors:  Yuwei Wang; David W Grainger
Journal:  Adv Drug Deliv Rev       Date:  2011-09-10       Impact factor: 15.470

2.  Retinoic acid inhibits NFATc1 expression and osteoclast differentiation.

Authors:  Wayne Balkan; María Rodríguez-Gonzalez; Manhui Pang; Isabel Fernandez; Bruce R Troen
Journal:  J Bone Miner Metab       Date:  2011-03-08       Impact factor: 2.626

3.  Ablation of the miRNA cluster 24 in cartilage and osteoblasts impairs bone remodeling.

Authors:  Veronika S Georgieva; Björn Bluhm; Kristina Probst; Mengjie Zhu; Juliane Heilig; Anja Niehoff; Bent Brachvogel
Journal:  Sci Rep       Date:  2022-06-01       Impact factor: 4.996

4.  The immunoreceptor tyrosine-based activation motif (ITAM) -related factors are increased in synovial tissue and vasculature of rheumatoid arthritic joints.

Authors:  Tania N Crotti; Anak A S S K Dharmapatni; Ekram Alias; Andrew C W Zannettino; Malcolm D Smith; David R Haynes
Journal:  Arthritis Res Ther       Date:  2012-11-12       Impact factor: 5.156

Review 5.  Breast cancer metastasis to the bone: mechanisms of bone loss.

Authors:  Yu-Chi Chen; Donna M Sosnoski; Andrea M Mastro
Journal:  Breast Cancer Res       Date:  2010-12-16       Impact factor: 6.466

6.  RANKL-Induced Btn2a2 - A T Cell Immunomodulatory Molecule - During Osteoclast Differentiation Fine-Tunes Bone Resorption.

Authors:  Michael Frech; Gregor Schuster; Fabian T Andes; Georg Schett; Mario M Zaiss; Kerstin Sarter
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-04       Impact factor: 5.555

7.  Cathepsin K null mice show reduced adiposity during the rapid accumulation of fat stores.

Authors:  Marcella Funicello; Michela Novelli; Maurizio Ragni; Teresa Vottari; Cesare Cocuzza; Joaquin Soriano-Lopez; Chiara Chiellini; Federico Boschi; Pasquina Marzola; Pellegrino Masiello; Paul Saftig; Ferruccio Santini; Rene St-Jacques; Sylvie Desmarais; Nicolas Morin; Joseph Mancini; M David Percival; Aldo Pinchera; Margherita Maffei
Journal:  PLoS One       Date:  2007-08-01       Impact factor: 3.240

8.  Angiopoietin-like 4 is over-expressed in rheumatoid arthritis patients: association with pathological bone resorption.

Authors:  Catherine Swales; Nicholas A Athanasou; Helen J Knowles
Journal:  PLoS One       Date:  2014-10-07       Impact factor: 3.240

9.  Silver nanoparticles do not alter human osteoclastogenesis but induce cellular uptake.

Authors:  Linda Pauksch; Marcus Rohnke; Reinhard Schnettler; Katrin S Lips
Journal:  Toxicol Rep       Date:  2014-10-18

10.  TMEM106B drives lung cancer metastasis by inducing TFEB-dependent lysosome synthesis and secretion of cathepsins.

Authors:  Samrat T Kundu; Caitlin L Grzeskowiak; Jared J Fradette; Laura A Gibson; Leticia B Rodriguez; Chad J Creighton; Kenneth L Scott; Don L Gibbons
Journal:  Nat Commun       Date:  2018-07-16       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.